FY2027 EPS Estimates for Cytokinetics, Incorporated (NASDAQ:CYTK) Lowered by Leerink Partnrs
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Investment analysts at Leerink Partnrs cut their FY2027 earnings per share (EPS) estimates for Cytokinetics in a research note issued on Wednesday, May 22nd. Leerink Partnrs analyst R. Ruiz now forecasts that the biopharmaceutical company will post earnings per share of $3.85 for the year, down from their […]
More Stories
Landman Season 3: News and Updates on Release Date and Trailer
Landman has gained popularity from its very first season. The season premiered on November 17, 2024, and continued for approximately...
A Dawn of Harmony: Envisioning True Peace Between the United States and Iran
By Stephen Zogopoulos, USNN World News January 17, 2026 – In the shadow of escalating protests across Iran and the...
Judge Restricts ICE Actions Against Protesters in Minnesota
By Kimberly Hayek A federal judge in Minnesota on Friday ruled that federal immigration agents can’t detain or use nonlethal...
Over Half of New Hires Land Jobs in a Month—With Tempered Expectations
By Panos Mourdoukoutas The labor market is becoming more efficient and flexible, with job seekers finding and accepting positions more...
Volodymyr Zelenskyy’s Net Worth: Assets, Salary, and Real Estate
Zelenskyy’s remark on the current situation of the abduction of Venezuela’s President and his wife has brought him to the...
Walz Responds to Reports of Federal Probe for Allegedly Obstructing Law Enforcement
By Jill McLaughlin Gov. Tim Walz called reports of a federal investigation into his recent public statements encouraging Minnesotans to...